๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The prognostic and predictive value of KRAS oncogene substitutions in lung adenocarcinoma

โœ Scribed by Villaruz, Liza C.; Socinski, Mark A.; Cunningham, Diana E.; Chiosea, Simion I.; Burns, Timothy F.; Siegfried, Jill M.; Dacic, Sanja

Book ID
120087018
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
700 KB
Volume
119
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Prognostic value of loss of heterozygosi
Prognostic value of loss of heterozygosity and KRAS2 mutations in lung adenocarcinoma
โœ Laura De Gregorio; Giacomo Manenti; Matteo Incarbone; Silvana Pilotti; Ugo Pasto ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 89 KB

The prognostic values of loss of heterozygosity (LOH) at loci frequently involved in non-small cell lung cancer and of KRAS2 gene mutations were studied in lung adenocarcinoma patients. LOHs were relatively common, ranging from 24% at chromosome 10p to 55% at chromosome 17p13. KRAS2 mutations at cod

Prognostic and predictive value of HER2/
Prognostic and predictive value of HER2/neu oncogene in breast cancer
โœ Shahla Masood; Marilyn M. Bui ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 735 KB

## Abstract Assessment of __HER2/neu__ oncogene has been used as both a prognostic and predictive marker for breast cancer. However, the choice of the best method to assess the status of __HER2/neu__ oncogene in breast cancer tissue remains controversial. A variety of techniques are available to de